India Neurology Devices Market Size and Share

India Neurology Devices Market Summary
View Global Report

India Neurology Devices Market Analysis by Â鶹ÊÓƵ

The India Neurology Devices Market size is expected to register a CAGR of 6.99% during the forecast period (2026-2031).

COVID-19 had a significant impact on the neurology devices market in India. In January 2022, a research study published in the Lancet stated that in India, several neuroimaging abnormalities have been noted in patients with COVID-19-associated mucormycosis, such as basal meningeal enhancement, entrapment of cranial nerves, watershed infarcts, areas of cerebritis, and cerebral abscesses, which showed lack of preparedness in neurological fields. Hence due to the abovementioned factors, COVID-19 had a notable impact on India's neurology devices market.

Furthermore, initiatives such as hospital launches for neurological disorders post-COVID are one of the key factors in market growth. For instance, in April 2022, Goutam Hospitals launched a neuro and multi-specialty hospital in Hyderabad. The hospital's large, eight-floor structure is furnished to meet the multispecialty demands of patients. It features 60 beds, 2 operating rooms, 4 intensive care units with 30 beds each, 10 recovery beds, 15 emergency beds, and 6 outpatient consultation rooms for patients to meet with specialists. The hospital offers multi-specialty care in neurology and neurosurgery and features cutting-edge diagnostic tools such as a neuro lab, biochemistry lab, CT scan, X-ray, and ultrasound. Thus, such initiatives are expected to increase market growth over the forecast period.

The key factors propelling the growth of the market in India are the increasing incidence of neurological disorders, huge investments by private players in neurology devices, an increase in R&D in the field of neurotherapy, and the rising aging population. The growth of the neurology devices market in India is also attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.

A study published in August 2021 in the National Library of Medicine, reported that in the past three decades, most studies in India have shown a high disease burden for specific diseases including stroke, epilepsy, headache, Parkinson's disease, and dementia, which are mostly reported for the urban Indian population. Similarly, various studies provide insight into the advantages of neuro therapies such as neurostimulation. For instance, the article published in the Current Psychiatric Reports in December 2021 concluded that in fear-related diseases such as PTSD and anxiety, neurostimulation is a promising therapy that avoids the discomfort of conscious exposure associated with traditional therapies. Thus, such studies are expected to boost market growth during the forecast period.

Moreover, increasing healthcare spending, increasing investment by medical device manufacturers, and increasing neurological disease prevalence are expected to drive the overall neurology devices market growth in India. For instance, in June 2022, the Indian Council of Medical Research (ICMR) and the Department of Health Research (DHR) unveiled the ICMR-DHR-Centre of Excellence (CoE) for fostering 'MedTech.' The ICMR-DHR-Centre of Excellence was launched at IIT-Bombay, IIT-Delhi, IIT-Guwahati, IIT-Hyderabad, IIT-Kanpur, IIT-Kharagpur, and IIT-Madras. These centers have been set to develop the products and technologies in synergy with the requirements of the National Health Mission, Ayushman Bharat, and the Public Health Program of the government. Through this initiative, medical device production is anticipated to increase and thereby boost the market growth in India. Due to the abovementioned factors, the Indian neurology devices market is anticipated to grow over the forecast period.

However, the high cost of neurology devices restrains the market growth.

Note: Market size and forecast figures in this report are generated using Â鶹ÊÓƵ’s proprietary estimation framework, updated with the latest available data and insights as of 2026.

Regulatory Landscape

Neurology devices in India are regulated by the Central Drugs Standard Control Organization (CDSCO) under the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules (MDR), 2017. MDR 2017 uses a risk-based framework (Class A to Class D), which shapes the technical documentation, quality system expectations, and licensing route for manufacturers and importers. Since February 11, 2020, medical devices have been under a licensing regime, with only specific Class A (non-sterile and non-measuring) products relying primarily on registration.

Regulatory outcomes can also be influenced by related compliance and tax interpretation for imported systems and parts used in advanced neurology care pathways. In June 2026, a CESTAT Mumbai ruling clarified classification of certain medical equipment parts and accessories under CTH 9018, enabling a concessional 12% IGST rate. Even though it is not neurology-specific, such rulings can affect the landed costs of imported device components for hospitals and service providers in high-acuity specialties.

Competitive Landscape

The Indian neurology devices market is moderately fragmented and competitive in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Major players include B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, and Nihon Kohden Corporation, among others.

India Neurology Devices Industry Leaders

  1. B. Braun Melsungen AG

  2. Boston Scientific Corporation

  3. Stryker Corporation

  4. Medtronic PLC

  5. Nihon Kohden Corporation

  6. *Disclaimer: Major Players sorted in no particular order
15.png

Market Opportunities and Future Outlook

Hospital-led technology adoption and capability upgrades are creating room for premium neurotherapies, navigation, and imaging modalities, alongside demand for scalable solutions across large tertiary networks. CARE Hospitals Bhubaneswar used Apple Vision Pro mixed reality to support brain surgery (July 2024). There have also been institutional steps to expand neurosurgical training capacity, including AIIMS Delhi initiatives announced in March 2024, which broadens the clinician and site base able to adopt advanced neurosurgery and neuromodulation platforms.

Regulatory maturation is also opening opportunities for manufacturers that can align portfolios to India-specific expectations around classification, labeling, and dossier requirements. CDSCO's April 1, 2025 notice on revising risk-based classification lists for cardiovascular and neurological devices indicates tighter alignment to the First Schedule of MDR 2017. That backdrop increases the value of regulatory strategy, clinical evidence planning, and India-ready quality systems for both global companies and local entrants, including those developing indigenous device programs and hospital innovation pipelines.

Recent Industry Developments

  • July 2026: AIIMS-Patna received a Government of India patent for a tubular brain retractor intended for deep-seated brain surgeries. The patented instrumentation supports safer access corridors in neurosurgical procedures and adds to the pipeline of indigenous, institution-origin devices that can move into broader clinical adoption and procurement.
  • June 2026: NIMHANS launched an Endovascular Research and Innovation (EVRI) laboratory and unveiled an indigenous mechanical thrombectomy device prototype named PARICHAY. The new lab infrastructure and in-house prototyping are focused on localizing stroke-intervention technologies, supporting faster iteration and clinician-led design inputs, and potentially reducing reliance on imported endovascular tools.
  • July 2024: CARE Hospitals, Bhubaneswar performed a brain surgery using Apple Vision Pro mixed reality technology to support surgical visualization and precision. The case reflected growing willingness among Indian tertiary centers to trial next-generation digital and visualization tools in neurosurgery, shaping vendor engagement around intraoperative guidance, imaging integration, and workflow software.

Table of Contents for India Neurology Devices Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Incidence of Neurological Disorders and Rise in the Aging Population
    • 4.2.2 Increase in R&D in the Field of Neurotherapies
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Equipment
    • 4.3.2 Stringent Regulatory Validation and Guidelines for New Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type of Device
    • 5.1.1 Cerebrospinal Fluid Management Devices
    • 5.1.2 Interventional Neurology Devices
    • 5.1.3 Neurosurgery Devices
    • 5.1.4 Neurostimulation Devices
    • 5.1.5 Other Types of Devices

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Johnson and Johnson
    • 6.1.4 Medtronic PLC
    • 6.1.5 MicroPort Scientific Corporation
    • 6.1.6 Nihon Kohden Corporation
    • 6.1.7 Smith & Nephew
    • 6.1.8 Stryker Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Research Methodology Framework and Report Scope

Market Definition and Coverage

For this study, the India neurology devices market covers medical devices used to diagnose, monitor, manage, or treat neurological conditions within India, across hospital and outpatient care settings, and reported as market value in USD.

Scope exclusions: Services, procedure fees, and drug therapy revenues are excluded, and only device-related revenues are counted.

Segmentation Overview

  • By Type of Device
    • Cerebrospinal Fluid Management Devices
    • Interventional Neurology Devices
    • Neurosurgery Devices
    • Neurostimulation Devices
    • Other Types of Devices

Data Sources, Market Sizing, and Validation

Desk Research

Desk work starts by building a clean view of demand and care capacity in India, and then we map that to device adoption. We mainly pull facts that are stable and publicly checkable, such as health system statistics, clinical prevalence ranges, and import signals that point to how fast neurology procedures and treatments are expanding.

Typical public sources used include publications from India's Ministry of Health and Family Welfare and the National Health Systems Resource Centre, hospital and program statistics from sources such as ICMR-linked studies, peer reviewed clinical journals for treated patient pool assumptions, customs and trade statistics from sources such as the Directorate General of Commercial Intelligence and Statistics, and standards references from sources such as the Bureau of Indian Standards. We also review company annual reports, investor presentations, and credible press coverage to understand product launches and pricing direction, and we use paid subscriptions for company financials and intelligence, patent databases, and shipment-level import and export checks where needed. The sources mentioned above are illustrative and not exhaustive, and additional references were used for data collection, validation, and research clarification.

Primary Interviews and Surveys

Primary calls and surveys help us pressure test adoption, pricing, and the pace of procedure growth across key neuro care settings in India. We speak with a mix of device makers, distributors, neurosurgeons, neurologists, and hospital procurement teams, so gaps from desk research are closed and assumptions are aligned with real buying and usage patterns.

Distribution of primary research fieldwork respondents

Company typeRespondent positionRegion
Top tier: 35% CXOs: 13%
Mid tier: 51% Functional/Unit leaders: 28%
Smaller Players: 14% Managers: 59%

Market-Sizing & Forecasting

Sizing is built using a combined top-down and bottom-up logic, where procedure volume and treated patient pool signals are used to reconstruct the demand pool for key neurology device uses in India, and then value is formed using realistic price bands. To avoid over-counting, the totals are then cross-checked using selective bottom-up approximations, such as sampled average selling price multiplied by implied unit volumes, channel checks with distributors, and supplier revenue sanity checks for the India exposure.

Inputs used in the model include, as examples, trends in stroke and movement disorder case loads, neurosurgery procedure throughput, hydrocephalus and CSF management utilization patterns, installed base and replacement cycles for neurostimulation systems, and the import intensity of high-value components that influences availability and pricing. Where primary inputs are incomplete, gaps are handled by using conservative adoption ramps anchored to nearby procedures and by applying sensitivity ranges that get re-tested with experts.

For forecasting, scenario analysis is used because demand depends on capacity expansion, physician adoption, and reimbursement behavior that can shift year to year. The forward view is built from near-term drivers like hospital expansion and technology upgrades, followed by longer-term adoption curves that are aligned with what clinicians and procurement teams expect.

Data Validation & Update Cycle

Validation is done by comparing the model output against independent signals, such as procedure growth direction, import and pricing movements, and reported revenue trends from relevant public filings. When outliers appear, we revisit assumptions like utilization per center, replacement timing, or price erosion, and then we re-contact interviewees if the variance stays unexplained.

A multi-step internal review is followed so definitions, calculations, and year-to-year movements are consistent before sign-off. Reports are refreshed annually, and interim updates are made when material events occur, such as major regulatory shifts, large tenders, or step changes in clinical adoption. Right before delivery, an analyst does a final update pass so the client receives the most current view.

Â鶹ÊÓƵ's India Neurology Devices Market Estimate Compared With Other Published Estimates

Published sizes for India neurology devices can look far apart because each publisher draws the line differently on what counts as a device, which years are treated as the base, and how pricing is projected through the forecast. Differences also come from how aggressively future procedure growth is assumed, and whether the estimate is checked against real-world care capacity signals.

Digital neurology software and remote neuro-monitoring platforms sit outside Â鶹ÊÓƵ's scope for this market, which is one reason some published totals run higher when they bundle device revenues with connected software subscriptions and monitoring services.

Benchmark comparison

SourceMarket SizeGaps in Research Methodology
Â鶹ÊÓƵ USD 0.72 B (2024)
Global Consultancy A USD 0.94 B (2024)This figure appears to use a broader product scope that can pull in additional neurology related diagnostic and monitoring revenues, and it may apply faster uptake assumptions without tying them back to procedure throughput and installed base realities.
Industry Publisher B USD 0.72 B (2024)Even when the total is similar, the mix can shift if replacement timing, distributor margin treatment, and currency conversion timing differ, which changes the implied average selling price path across device groups.

Overall, the spread is mainly explained by what gets included beyond core neurology devices and by how fast price and adoption are assumed to move. By keeping the inputs tied to treated patient pools, procedure throughput, and realistic price bands, the resulting market value stays traceable and easier to recreate and update.

Key Questions Answered in the Report

What is the current India Neurology Devices Market size?

The India Neurology Devices Market is projected to register a CAGR of 6.99% during the forecast period (2026-2031)

Who are the key players in India Neurology Devices Market?

B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC and Nihon Kohden Corporation are the major companies operating in the India Neurology Devices Market.

What years does this India Neurology Devices Market cover?

The report covers the India Neurology Devices Market historical market size for years: 2022, 2023, 2024 and 2025. The report also forecasts the India Neurology Devices Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.

Page last updated on:

India Neurology Devices Market Report Snapshots